|TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes|
Thanks to all the attendees who made the 11th edition of Private Inv€stments Day, of Lyonbiopole, a success !
Biotech, Medtech, Digital Health Tech... the world health market covers all these domains. This is why Lyonbiopole attended MEDICA and coorganized the International Congress on Infectious Diseases and Immunotherapies (I4ID) with MabDesign and BIOASTER.
Events to come : Register now at the Probiotics & Microbiota Intestinal event, on February, 04th, and save-the-date for the next S3martMed European Brokerage Event on March, 24th in Lyon. Registration will open soon !
|BioEurope FallThis mission, funded as part of the International Development Plan of the Auvergne-Rhône-Alpes Region, allowed a delegation of 10 companies, members of Lyonbiopole, to take advantage of the partnering sessions of the event and network with 2,300 companies from 61 countries!|
|MEDICAThis year again, Lyonbiopole and I-Care Lab piloted the MEDICA regional trade mission. This support, funded by the International Development Plan of the Auvergne-Rhône-Alpes Region, benefited to 6 companies including 4 Lyonbiopole's members who gained visibility through the regional pavilion. The opportunity, during 4 days, to participate in this global meeting of the medical industry in Düsseldorf to discover the latest technological innovations, identify distributors and meet potential partners, start-ups or large groups. MEDICA was also the opportunity to officially sign the MoU with Medical Alley Association as part of the MAGIA European Alliance.|
|ACS Biotech winner of the Innovation AwardsThis year again, the Lab Meeting award of Bref Eco, category held by Auvergne-Rhône-Alpes competitiveness clusters, goes to a Lyonbiopole's member, ACS Biotech, for its project "Cartilage Gel". It is an injectable solution for cartilage lesions repair. A major breakthrough in regenerative medicine based on cell therapy solutions. A great recognition of the work carried out by the health ecosystem on the innovations of the future!|
|1st Regional Health ConferenceThis first edition, base on the theme "Innovation & Territory", gathered health actors of Auvergne-Rhône-Alpes, at the Hôtel de Région of Lyon, in front of 350 attendees. Lyonbiopole was a part of the 2nd round table "Innovation serving health sector companies competitiveness". A great opportunity to hightlight the strengths of our territory.|
|Entrepreneurship award AAUL/LyonbiopoleEvery year, the "Association des Amis de l'Université de Lyon" awards prizes to students, post-docs, lecturers and researchers from higher education institutions at the University of Lyon-Saint-Etienne. This honorary title was awarded to AXO Science, a member of Lyonbiopole, at a ceremony attended by many personalities from the University of Lyon.|
|11th edition of the Private Inv€stments DayNearly 160 people gathered for this 11th edition at Boehringer Ingelheim Santé Animale. At the program of this event, two round tables: "Resilience, Key to Entrepreneurial Success" & "Financial Analysis: Defending Its Value and Standing"; a pitch session enabled 14 companies looking for funding to present their projects to a panel of 40 international investors. Finally, the afternoon was devoted to + 100 individual partnering meetings between entrepreneurs and investors. [...]|
|Lyonbiopole in action !As part of its new communication offer, Lyonbiopole honors one of these members in a video every month! Discover the 2nd video of this series : Orphelia, 2 new products on the market. [...]|
|New membersDiscover Lyonbiopole's new members : Meersens, the first AI solution on the data of the exposome; MaQuestionMedicale.fr, patient/doctor teleconsultation platform; Vidium, the Google Map of gene networks; Falgagen, a company supporting the Life Science industry in the conception, development, and integration of medical devices. [...]|
|Focus onThe fundraising now allows Laclarée to hire new talents in order to prepare the next fully integrated version of eyeglasses for a real beta-test, a key step before industrialisation in 2021 and market launch in 2022. [...]|
|October 30th, 2019EDAP to Introduce New Endo-UP® Endourology Platform During the 2019 World Congress of Endourology||November 5th, 2019Nosopharm welcomes Jacques Biton and Frédéric Hammel to its supervisory board||November 7th, 2019CALIXAR and COSMO BIO to conclude distribution agreement|
|November 14th, 2019CarThera to present update on SonoCloud-9 clinical study at upcoming SNO Congress in Phoenix||November 15th, 2019Calixar: new grant for membrane protein stabilization chemistry||November 18th, 2019CarThera and KIYATEC collaborate in effort to bring personalized medicine to patients stricken by brain cancer|
|November 19th, 2019Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate||November 28th, 2019GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm agree to launch a new clinical study of temelimab in multiple sclerosis||Décember 6th, 2019Promise Proteomics positions itself on the diagnostics and personalised medicines|
|Décember 9th, 2019CarThera signs a strategic collaboration with Lantheus for its SonoCloud device microbubbles|
|3rd Probiotics and Microbiota Intestinal Day|
February 4th, 2020Save-the-date - S3martMed Brokerage Event
March 24th, 2020
See All events
EUROPE & INTERNATIONAL
Before January 8th, 2020
Before February 9th, 2020
Before February 13th, 2020
Before April 22th, 2020
Décember 10th, 2019
January 12th, 2020
March 11th, 2020
This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.